1419 — Human Health Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- HK$322.62m
- HK$17.26m
- HK$644.43m
- 89
- 95
- 26
- 84
Annual cashflow statement for Human Health Holdings, fiscal year end - June 30th, HKD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 169 | 445 | 239 | 26.6 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 7.21 | -13.2 | 71.1 | -6.06 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -158 | -199 | 280 | -75.3 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 85.5 | 296 | 664 | 13.2 | — |
| Capital Expenditures | -14.1 | -76.5 | -84 | -39.5 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 9.28 | -127 | -251 | -8.13 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.77 | -203 | -335 | -47.6 | — |
| Financing Cash Flow Items | -2.87 | -2.83 | -7.93 | -7.86 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -59.3 | -67.4 | -178 | -125 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 22 | 25 | 149 | -159 | — |